Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Clinical trial NCT02975206 · COMPLETED
Trial details
- NCT number
- NCT02975206
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-01-16
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.